Navigation Links
Chembio Provides Business Update
Date:1/3/2012

Opportunities in Chembio's Pipeline - We are working on potential new opportunities to expand our target markets, and product offerings, and will provide updates as available. No binding commitments have been made concerning any of these potential opportunities; and there is no assurance that any of them will occur.  

We are most grateful for the hard work of our employees during 2011 and for the support of our investors, and we look forward to an exciting year in 2012.

 

About Chembio Diagnostics

Chembio Diagnostics, Inc. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $7 billion point-of-care testing market. Chembio's two FDA PMA-approved, CLIA-waived, rapid HIV tests are marketed in the U.S. by Alere North America, Inc. (formerly Inverness Medical Innovations, Inc.).  Chembio markets its HIV STAT-PAK® line of rapid HIV tests internationally to government and donor-funded programs directly and through distributors.  Chembio has developed a patented point-of-care test platform technology, the Dual Path Platform (DPP®) technology, which has significant advantages over lateral-flow technologies. This technology is providing Chembio with a significant pipeline of business opportunities for the development and manufacture of new products based on DPP®. Headquartered in Medford, NY, with approximately 140 employees, Chembio is licensed by the U.S. Food and Drug Administration (FDA) as well as the U.S. Department of Agriculture (USDA), and is certified for the global market under the International Standards Organization (ISO) directive 13.485. For more information, please visit: www.chembio.com.

 

Forward-Looking Statements

Statements contained herein that are not historical facts may be forward-looking statements w
'/>"/>

SOURCE Chembio Diagnostics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Chembio Reports 3rd Quarter 2011 Results
2. Chembio to Host Conference Call to Discuss 3rd Quarter 2011 Financial Results
3. Chembio Diagnostics CFO Richard J. Larkin Among the Recipients of "2011 CFO of the Year" Award from Long Island Business News
4. Medical Alarm Concepts Releases Initial Cut of New Television Commercial Scheduled for January Airing - Provides Investor Update
5. CareFusion Provides Update on Previously Announced Ventilator Recall
6. Generex Provides Update on Bloomberg TV Breast Cancer Vaccine Segment
7. PDL BioPharma Provides Fourth Quarter 2011 Revenue Guidance of $72 Million
8. Onyx Pharmaceuticals Provides Update on Carfilzomib at 53rd American Society of Hematology Annual Meeting
9. Big Blue Test 2011 Provides Life-Saving Insulin and Supplies to More Than 8,000 People in Need
10. Lilly Provides Additional Funding to Infectious Disease Research Institute to Identify New Tuberculosis Therapies
11. Linking EudraCT and ClinicalTrials.gov Records Provides Huge Benefit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... N.J. , Jan. 14, 2014 InformEx, ... and sellers of high-value chemistry, will hold the 30 th ... Miami Beach Convention Center from January 21-24. ... 3,500 attendees from top pharmaceutical, fine chemical and specialty chemical ...
(Date:1/14/2014)... 14, 2014 Animal Emergency Critical Care, a LifeCentre partner practice, ... is the first in Loudoun County ... Dr. Susan M. Barnes , Medical Director, is a ... Dr. Cole Taylor , are avid scuba divers. "As altitude ...
(Date:1/14/2014)... PORT WASHINGTON, New York , January 14, ... the leading provider of Closed System Transfer Devices (CSTD) for hazardous drugs, ... sales growth for the fourth straight year.   ... of exposure for pharmacy technicians, pharmacists, nurses and ...
Breaking Medicine Technology:Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Equashield's Sales Grow by 60% in 2013 2
... March 14, 2011 Bionovo, Inc. (Nasdaq: BNVI ) ... quarter of fiscal year 2010 ended December 31, 2010 on Tuesday, ... webcast to review the financial results on Tuesday, March 15, 2011, ... call by dialing 1-888-428-7458, or can listen via a live audio ...
... /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: CHBT ) ... distributor of probiotics products in China, today announced the ... held on Wednesday, March 9, 2011 for stockholders of ... Offices at No. 26, Orient Global Headquarter, Lane 118 ...
Cached Medicine Technology:China-Biotics, Inc. Announces the Results of the 2010 Annual Meeting of Stockholders 2
(Date:4/22/2014)... computational tool developed at the University of Utah (U ... mutations in three separate cases, U of U researchers ... The American Journal of Human Genetics . The ... undiagnosed illnesses and unknown gene mutations by analyzing the ... for genes are made, in individual patients and small ...
(Date:4/22/2014)... cell lung cancer are 70 years of age or ... are not well represented in clinical trials. Therefore, the ... reach evidence based clinical recommendations. , In 2010, the ... Cancer Group along with the International Society for Geriatric ... for elderly patients with non-small cell lung cancer (NSCLC), ...
(Date:4/22/2014)... -- When mothers are exposed to trauma, illness, alcohol ... single molecular trigger in brain cells that can go ... disorder and some forms of autism. , Until now, ... impacted the cells of a developing brain. Past studies ... to alcohol or drug abuse or she experiences some ...
(Date:4/22/2014)... (April 22, 2014) Cedars-Sinai stroke intervention researchers have ... and Stroke, part of the National Institutes of Health, ... multicenter Phase II clinical trial of an experimental drug ... used in combination with recombinant tissue plasminogen activator, or ... ischemic strokes shortly after onset. In laboratory rodent studies, ...
(Date:4/22/2014)... on results of a clinical trial led by ... Drug Administration (FDA) approved a molecularly targeted drug ... has progressed after standard chemotherapy has failed. , ... announced by the manufacturer, Lilly Oncology, of Indianapolis. ... it will be sold under the name Cyramza, ...
Breaking Medicine News(10 mins):Health News:Applying math to biology: Software identifies disease-causing mutations in undiagnosed illnesses 2Health News:Applying math to biology: Software identifies disease-causing mutations in undiagnosed illnesses 3Health News:EORTC and SIOG update expert opinion on management of elderly patients with NSCLC 2Health News:Life stressors trigger neurological disorders, researchers find 2Health News:$8 million NIH grant will fund multicenter clinical trial of stroke intervention drug 2Health News:$8 million NIH grant will fund multicenter clinical trial of stroke intervention drug 3Health News:FDA approves first targeted drug for advanced stomach cancer 2
... lead character smokes is not as effective a method as ... the appeal of smoking to , are non-smokers. ... the June issue of the journal Tobacco Control. ... whom were current smokers, aged 12-24 years in Australia, over ...
... found that diabetes is associated with decreases in life expectancy, ... ,The study, published in Archives of Internal Medicine, ... with diabetes at age 50 and older appear not to ... without cardiovascular disease, than individuals without diabetes. ,Globalization ...
... Just a short walk from some of Tokyo's most chic ... for long, if the government gets its way . In ... baskets loaded with their fresh catch at Tsukiji market, minutes ... luxury shops and corporate headquarters. The world's largest ...
... disease in monkeys with the help of human stem cell ... in the Proceedings of the National Academy of Sciences, the ... and grew them into large numbers in the laboratory. ... of monkeys with a severe form of chemically induced Parkinson's ...
... ballet shoe are booming in Britain, where the latest unusual ... environment . Since 2000, Vic Fearn and Company have been ... Coffins". The firm recently expanded their range to ... from the clients," said John Gill, head of the Nottingham, ...
... is dumped in Urali Devachi, about 25 kilometers from the ... villagers . ,Urali Devachi village has been turned into ... the citys nearly five million plus population. ,The ... to Urali Devachi, located on Pune-Saswad road, in 1999. ...
Cached Medicine News:Health News:Diabetes Reduces Life Expectancy, Increases Heart Disease Risk 2Health News:Traders Smell Something Fishy in Tokyo Market Move 2Health News:Traders Smell Something Fishy in Tokyo Market Move 3Health News:To Die For: Rolls-Royce and 'green' Coffins at British Funerals 2
Inquire...
Use the Mo Bio Vortex adapter to process multiple samples at the same time. The adapter holds tubes horizontally to increase cell lysis and mixing efficiency. Ideal for bead beating procedures....
Use the Mo Bio Vortex adapter to process multiple samples at the same time. The adapter holds tubes horizontally to increase cell lysis and mixing efficiency. Ideal for bead beating procedures....
... Mo Bio Vortex Adapter in conjunction with the ... Using the Mo Bio Vortex Adapter is ... Fast Prep machines which offer the same technology. ... centrifuge tubes at one time and will fit ...
Medicine Products: